Liver Transplantation for Primary Sclerosing Cholangitis (PSC) With or Without Inflammatory Bowel Disease (IBD)—A European Society of Organ Transplantation (ESOT) Consensus Statement

ESOT Guidelines Taskforce

Research output: Contribution to journalArticlepeer-review

17 Downloads (Pure)

Abstract

Primary sclerosing cholangitis (PSC) is the classical hepatobiliary manifestation of inflammatory bowel disease (IBD) and a lead indication for liver transplantation (LT) in the western world. In this article, we present a Consensus Statement on LT practice, developed by a dedicated Guidelines’ Taskforce of the European Society of Organ Transplantation (ESOT). The overarching goal is to provide practical guidance on commonly debated topics, including indications and timing of LT, management of bile duct stenosis in patients on the transplant waiting list, technical aspects of transplantation, immunosuppressive strategies post-transplant, timing and extension of intestinal resection and futility criteria for re-transplantation.
Original languageEnglish
Article number11729
Number of pages14
JournalTransplant international
Volume36
DOIs
Publication statusPublished - 29 Sept 2023

Bibliographical note

Funding:
All costs related to taskforce and workgroup meetings were covered by ESOT, without external funding.

Keywords

  • retransplantation
  • PSC
  • liver transplantation
  • immunosuppression
  • IBD

Fingerprint

Dive into the research topics of 'Liver Transplantation for Primary Sclerosing Cholangitis (PSC) With or Without Inflammatory Bowel Disease (IBD)—A European Society of Organ Transplantation (ESOT) Consensus Statement'. Together they form a unique fingerprint.

Cite this